Theme: Novel Therapeutic Strategies in Vaccines & Vaccination

Middle East Vaccines-2015

Renowned Speakers

Middle East Vaccines-2015

"Middle East Vaccines -2015 Organizing Committee" congratulates our previous conference best poster award winners and Young Researcher Award winners. 
 
4th International Conference on Vaccines & Vaccination, September 24-26, 2014 Valencia, Spain
 
Rong Xu, Cardiff University, UK
Title: IL-34 suppresses Candida albicans induced TNF-α production by M1 macrophages through down-regulation of Dectin-1 and TLR2 expression
 
Daisy Vanrompay, Ghent University, Belgium
          Title: Protection of chickens against Chlamydia psittaci challenge by  mucosal immunization with the major outer membrane protein
 
Silvia Vendetti, Istituto Superiore di Sanita, Italy
          Title: Retinoic acid promotes long lasting mucosal and systemic immune responses after mucosal priming and systemic boosting in mice
 

With the overwhelming success of 4th International Conference onVaccines & Vaccination in Spain, OMICS International welcomes you to attend the Middle East Global Summit and Expo on Vaccines & Vaccination which will be held on September 28-30, 2015 at Dubai, UAE.

Vaccine Summit-2015 anticipating  thought provoking presentations and eminent Keynote lectures. The attending delegates include Editorial Board Members and leading international representatives from the research and development of vaccines. This would provide an excellent opportunity for the participants from Universities, Institutes and other Private Organizations to interact with the World class Scientists and renowned speakers.

Abstract Submission Guidelines: Abstracts should be 250 words in length followed by a biography of the presenting author of upto 100 words. All submitted abstracts will be thoroughly examined by the expert committee. It is recommended to make your submissions at the earliest to give enough feedback time. Final submissions for speaker and poster categories will be accepted only till March 30, 2015. Request a sample abstract format at : dubaivaccines@conferenceseries.net

 

The scientific sessions of the Vaccines & Vaccination conferences includes all the ongoing research in vaccines & vaccination. 

Middle East Vaccines-2015 enables a common platform for the participants to discuss their research in order to establish a scientific network between the academia and industry leads to foster collaboration and to evaluate the emerging issues, technologies and innovations leads to explore new possibilities and improving the existed opportunities.

Experts outlook on our previous conferences
 

  • Mahesh Mohan, Tulane University Health Science Center, USA
    I enjoyed attending the vaccines business meeting and also had the opportunity to meet other researchers and learn about their research for future collaborations. The talks were informative and I had the opportunity to learn new information. Overall, I enjoyed the conference."
  • Martin D'Souza, Mercer University, USA
    Many thanks as well for organizing this very focused meetings on vaccines 
  • De-Chu Christopher, International Vaccine Institute, Korea
    Many thanks for organizing this great forum for brain storms to occur nonstop
  • Donald E. Greydanus, Western Michigan University School of Medicine, USA
    Thank you and I enjoyed the vaccines conference as well as the chance to meet with Dr. Gedela Babu to discuss various issues. I wish you continued success with your conferences!
  • Hyunah Lee, Sungkyunkwan University School of Medicine, Korea
    It was my great pleasure attending and presenting my paper at the Vaccines-2012. I am sure that the conference was successful. And your hospitality left me with deep impression.

clinical vaccinology

Clinical Vaccination should be the most economical and sustainable way of combating with infectious diseases. Vaccines against diphtheria, tetanus, measles, mumps, rubella, polio, hepatitis, pneumococcus, and Haemophilus influenzae meningitis have lowered the incidence and mortality more than 97%.

During late Vaccine 1.0 and early 2.0 periods, with the development of new bacterial and viral vaccines, recombinant vaccines, and of new technologies, and with the need of scale up production and the increase in the investment for large-scale clinical trials, many local producers disappeared and were acquired by bigger companies. Eventually the vaccine industry became increasingly concentrated with a small number of major players. Until the end of the Vaccine 2.0 era, major companies had over 80% of the global market.

A turning point came during mid-1990s when the global vaccine market size was less than 5 billion dollars. The Vaccine 2.0 era was triggered by the success of premium conjugate vaccines targeting H. influenza type b (Hib) and pneumococcus. The tide was reversed and the vaccine industry became a very competitive area. From then, the vaccine market began to grow at double-digit rates and was expected to reach 15 billion dollars in 2010. However, the real vaccine market grew faster than expected and already passed 20 billion dollars in 2010. The total vaccine market sales in 2012 were estimated to be over 25 billion dollars 

These market values will be covered by international speakers. This forum enables a common platform for the participants to discuss their research in order to establish a scientific network between the academia and industry leads to foster collaboration and to evaluate the emerging issues, technologies and innovations leads to explore new possibilities and improving the existed opportunities.

Our previous attendee’s analysis reveals:

• 90% are involved in or make final purchase decisions
• 60% of our previous conferences visited the Exhibit Floor 3 or more times
• 50% came to keep abreast of new products and technology
• 40% came to find a new supplier, technology or product
 

Categories Available!!

Elite sponsor 
Gold sponsor 
Silver sponsor 
Exhibition sponsor 
Lunch / cocktail sponsor 
Coffee break sponsor 
Conference delegate bag sponsor 
Academic partner 
Corporate partner 
Keynote sponsor 
Outside back cover (color)
Inside front cover (color)
Inside back cover (color) 
Conference Banner Sponsor

 

 
The 4th International Conference on Vaccines & Vaccination, hosted by the OMICS International. It was held in
 
September 24-26, 2014 Valencia, Spain. Generous response and active participation was received from the Editorial
 
Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2014 from OMICS International. Also, the conference was carried out through various sessions, in which the discussions were held on the following scientific tracks:
 
Overview
 
 
• Vaccines and the Basic Immune System
 
• New Approaches for B and T Cells
 
• Cellular and Molecular-Based Vaccines
 
• Vaccines Against Infectious Diseases
 
• Manufacturing, Production and Development of Vaccines
 
• Regulatory and Ethical Issues of Vaccines and Public Acceptance
 
• Current Issues on Clinical Evaluation and Field Trials of Vaccines
 
• Modern Technologies in Vaccine Discovery and Development
 
• Age-Specific Immune Response to Vaccination
 
• Novel Delivery technologies in Vaccines and many more...
 
The response to 4th International Conference on Vaccines & Vaccination was huge and was attended by about
 
550 attendees representing 55 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included
 
 
Jeffrey B Ulmer, Novartis Vaccines USA
 
Ray Spier, Former President, International Society for Vaccines, UK
 
Michael G Hanna, CEO, Vaccinogen, Inc., USA and many more...
 
All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions
 
at Vaccines-2014.
 
All accepted abstracts have been indexed in OMICS International -Journal of Vaccines & Vaccination as a special issue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.
 
Conference Proceedings
 
 
Sponsors and exhibitors
 
Sanofi Pasteur SA
 
U.S. Headquarters, Discovery Drive, Swiftwater, PA 18370
 
Vaccinogen Inc.,
 
5300 West view Dr # 406, Frederick, MD 21703, United States
 
Cellular Technology Limited (CTL)
 
North & South America
 
CTL Headquarters, 20521 Chagrin Blvd., Shaker Heights, OH 44122-5350 USA,
 
Gen Phar
 
600 Seacoast Pkwy # 100,
 
Mt Pleasant, SC 29464, United States
 
 
 
OMICS International, the global leader in organizing annual “International conferences and Exhibitions on Vaccines and Vaccinations” The Annual Vaccines Conferences provides high-quality, current reports of scientific progress and best practices featured in both invited presentations and submitted oral abstracts and posters. The Global Vaccines Conferences and Expos organized by OMICS International, bring together the diverse disciplines involved in the research and development of vaccines and associated technologies for disease control through immunization. By drawing upon an global audience of CEOs, CSOs, scientists and researchers, healthcare professionals and trainees, veterinarians, vaccine manufacturers, and public health officials, the conference is designed to encourage the exchange of ideas across a broad range of disciplines.
 
 
Highlights of Annual Global Vaccines Conferences-OMICS International
 
 
• Keynote forum
 
• Exhibitions
 
• Company Presentations
 
• Speaker Forum
 
• Workshops and Symposia’s
 
• B2B Meetings
 
• One to One meeting
 
• Special Session for Students
 
• Scientific writing
 
• Journal review
 
• Grant writing
 
• Strategies for building a scientific career
 
• Scientific careers outside of research
 
• Company Promotions
 
• Young Research Forum
 
• Best Poster Awards
 
• Certification by the “International Organizing committee” and many more...
 
 
 
 
The 2nd International Conference on Vaccines & Vaccination, hosted by the OMICS International . It was held in August 20-22, 2012 in Hilton Chicago/Northbook, USA. Generous response and active participation was received from the Editorial Board Members of OMICS International Journals as well as from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2012 from OMICS International. Vaccines 2012 hosted 300+ attendees representing 55 countries from different corners of the world. The conference was carried out through various sessions, in which the discussions were held on the following
 
scientific tracks:
 
• Vaccines and the Basic Immune System
 
• New Approaches for B and T Cells
 
• Cellular and Molecular-Based Vaccines
 
• Vaccines Against Infectious Diseases
 
• Manufacturing, Production and Development of Vaccines
 
• Regulatory and Ethical Issues of Vaccines and Public Acceptance
 
• Current Issues on Clinical Evaluation and Field Trials of Vaccines
 
• Modern Technologies in Vaccine Discovery and Development
 
• Age-Specific Immune Response to Vaccination and many more...
 
Conference Proceedings:
 
 
 
 
 
 
The response to 2nd International Conference on Vaccines & Vaccination was huge and was attended by about
 
300 attendies representing 25 countries from different corners of the world. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the keynote forum. The list included
 
 
De-Chu Christopher Vaxin Inc., USA
 
John Dong GenPhar, USA
 
Donald E. Greydanus Western Michigan University School of Medicine, USA
 
Eli Young OpSaniTx, USA
 
Takashi Kei Kishimoto Selecta Biosciences, USA
 
Daniel H Zimmerman CEL-SCI Corporation, USA
 
Gerardo Kaplan FDA, USA
 
Kei Amemiya U.S. Army Medical Research Institute of Infectious Diseases, USA
 
Haval Shirwan University of Louisville, USA and many more...
 
All the above mentioned Honorable Guests and keynote speakers gave their energetic and fruitful contributions
 
at Vaccines-2012.All accepted abstracts have been indexed in OMICS International- Journal of Vaccines & Vaccination as a specialissue. The theme of this Conference was on “Prospects and Development of Prophylactic & Therapeutic Vaccines”. Based on this, speaker’s discussions included many recommendations.
 
 
 
The International Conference and Exhibition on Vaccines & Vaccination (Vaccines-2011) was held on November
 
22-24, 2011 in Philadelphia Airport Marriott Hotel, USA. This successful conference organized by OMICS Group brought together Medical Specialists, Researchers and Vaccine Developers who were delighted with the many speeches, presentations, and discussions, which demonstrated the determination to innovate and improve knowledge on Vaccines.Vaccines-2011, helped to open new ideas, advanced technologies, innovative approaches towards Vaccines. Several speakers from almost 30 countries have participated in this conference which was carried out through several sessions with the theme “Current Strategies in Vaccination”.
 
Conference highlighted the following topics:
 
• Vaccines and the basic immune system
 
• New approaches for B and T cells
 
• Cellular and molecular-based vaccines
 
• Vaccines against infectious diseases
 
• Therapeutic vaccine manufacturing, production and development
 
• Logical and ethical issues and vaccines
 
• Experimental and clinical evaluation of therapeutic vaccines
 
• Basic Vaccinology and modern vaccine discovery technologies and many more...
 
The Luxurious accommodation during the conference also created a relaxed and informal atmosphere with
 
aright setting for highly interactive sessions where the speakers shared the knowledge on current issues and
 
strategies of Vaccines and Vaccination.
 
We take an immense pleasure in thanking our Keynote Speakers:
 
Gary Alan Flory Virginia Department of Environmental Quality, USA
 
Gregory J. Tobin Biological Mimetics, Inc. (BMI), USA
 
Kei Amemiya US Army Medical Research Institute, USA
 
Edmund J. Gosselin Albany Medical College, USA
 
Mansour Mohamadzadeh University of Florida, USA and many more...
 
Vaccines 2011 hosted 200+ attendees representing 30 countries from different corners of the world.
 
Conference Proceedings:
 
 
 
We are grateful to all speakers, scientific societies, governmental and non-governmental institutions, Professors, scientists, representatives of patient groups from throughout the world for their commitment and the support. We would like to thank our organizing committee members for providing advice on the agenda, and in supporting the conference. We are grateful to NIH, GSK, Sanofi Pasture, and other sponsors for their invaluable support for the success of the event. Journal of Vaccines & Vaccination and Journal of Clinical & Cellular Immunology have published all papers presented at this meeting as a special issue. With the overwhelming response and suggestions and feedbacks from our previous attendees. OMICS International is organizing its Global Vaccines conferences in major countries across the globe: We are also obliged to various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Vaccines-2012.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 28-29, 2015
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View

Media Partners

Testimonials